抄録
There is growing body of evidence that nitric oxide (NO)-cGMP-PKG signaling plays a central role in negative regulation of cardiovascular (CV) responses and its disorders through suppressed Ca2+ dynamics. Other lines of evidence also reveal the stimulatory effects of this signaling on some CV functions. Recently, transient receptor potential (TRP) channels have received much attention as non-voltage-gated Ca2+ channels involved in CV physiology and pathophysiology. Available information suggests that these channels undergo both inhibition and activation by NO via PKG-mediated phosphorylation and S-nitrosylation, respectively, and also act as upstream regulators to promote endothelial NO production. This review summarizes the roles of NO-cGMP-PKG signaling pathway, particularly in regulating TRP channel functions with their associated physiology and pathophysiology.
本文言語 | 英語 |
---|---|
ページ(範囲) | 347-360 |
ページ数 | 14 |
ジャーナル | Expert Review of Clinical Pharmacology |
巻 | 3 |
号 | 3 |
DOI | |
出版ステータス | 出版済み - 5月 2010 |
!!!All Science Journal Classification (ASJC) codes
- 薬理学、毒性学および薬学(全般)
- 薬理学(医学)